Vertical Banded Gastroplasty in the Severely Obese under Age Twenty-One

Mason1, Scott, Doherty

  • 1Department of Surgery, University of Iowa College of Medicine, Iowa City, IA, 52242-1086, USA.

Obesity Surgery
|February 1, 1995
PubMed

Insights

Vertical banded gastroplasty (VBG) is an effective surgical treatment for severe obesity in adolescents. This study shows VBG leads to significant sustained weight reduction and improved health outcomes in patients under 21.

Area of Science:

  • Pediatric Surgery
  • Bariatric Surgery
  • Adolescent Health

Background:

  • Severe obesity in individuals under 21 poses risks to normal development.
  • Surgical intervention is a viable option for this population.
  • Vertical banded gastroplasty (VBG) offers effective treatment with preserved digestion and absorption.

Purpose of the Study:

  • To evaluate the long-term outcomes of vertical banded gastroplasty (VBG) in severely obese patients under 21 years of age.
  • To assess the safety and efficacy of VBG in this specific demographic.

Main Methods:

  • Retrospective outcome review of 47 severely obese patients.
  • Patients were under 21 years of age at the time of VBG surgery.
  • Follow-up data collected at 5 and 10 years post-surgery.

Main Results:

  • No operative mortalities, leaks, or wound infections were reported.
  • Average BMI decreased significantly: from 48.1 to 36.2 kg/m² at 5 years (n=25) and 49.6 to 39.2 kg/m² at 10 years (n=14).
  • Follow-up rates were 74% for both patient groups.

Conclusions:

  • Sustained weight reduction through VBG improves general health and quality of life.
  • Adherence to surgical technique, including intraoperative pouch volume measurement, is crucial for success.
  • Proper technique minimizes risks of pouch enlargement, weight regain, reflux, and revision surgery.

Related Concept Videos

Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...